Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2024-07-12 00:00:00 ET · period of report 2024-07-11 · accession 0001735276-24-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-12 | 2024-07-11 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale | $261.00 | -7,093 | 73.4K | -9% | -$1.85M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-11 | S | D | 7,093 | $261.00 | 73,441 | D | — | — |